Skip to main content

Market Overview

25 Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • Aimmune Therapeutics Inc (NASDAQ: AIMT) rose 46.2 percent to $37.51 in pre-market trading in response to failed DBVT peanut allergy trial.
  • Evoke Pharma Inc (NASDAQ: EVOK) rose 22.4 percent to $4.21 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
  • Agenus Inc (NASDAQ: AGEN) rose 17.6 percent to $5.09 in pre-market trading as the company disclosed that GSK's shingle vaccine received FDA approval.
  • BroadSoft Inc (NASDAQ: BSFT) rose 16.9 percent to $63.00 in pre-market trading after Reuters reported that Cisco is nearing a deal to acquire BroadSoft.
  • AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) shares rose 12.5 percent to $2.25 in pre-market trading after the company disclosed that DSUVIA clinical trial results selected as a top abstract for oral presentation at ASA's Annual Meeting.
  • Xunlei Ltd (NASDAQ: XNET) shares rose 8.8 percent to $7.16 in pre-market trading after surging 25.33 percent on Friday.
  • Deltic Timber Corp (NYSE: DEL) shares rose 7.1 percent to $95.39 in pre-market trading after Potlach announced plans to merge with Deltic.
  • Renren Inc (NYSE: RENN) rose 6.4 percent to $10.18 in pre-market trading after gaining 2.68 percent on Friday.
  • Hoegh LNG Partners LP (NYSE: HMLP) rose 5.9 percent to $20.60 in the pre-market trading session after gaining 0.52 percent on Friday.
  • Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares rose 5.7 percent to $1.87 in pre-market trading after the company announced a European Patent for RLX-R18.
  • Scorpio Bulkers Inc (NASDAQ: SALT) rose 5.5 percent to $8.65 in pre-market trading. Scorpio Bulkers posted a Q3 loss of $0.15 per share on revenue of $38.61 million.
  • NovaGold Resources Inc. (USA) (NYSE: NG) rose 4.6 percent to $4.31 in pre-market trading after dropping 0.48 percent on Friday.
  • VF Corp (NYSE: VFC) shares rose 4 percent to $69.00 in the pre-market trading session after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
  • Caesars Entertainment Corp (NASDAQ: CZR) rose 3.7 percent to $12.65 in pre-market trading after gaining 1.24 percent on Friday.
  • Halliburton Company (NYSE: HAL) shares rose 3.2 percent to $44.69 in pre-market trading after the company reported stronger-than-expected profit for its third quarter on Monday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • DBV Technologies SA - ADR (NASDAQ: DBVT) fell 44.6 percent to $26.61 in pre-market trading after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
  • 8Point3 Energy Partners LP (NASDAQ: CAFD) fell 11.7 percent to $13.70 in pre-market trading after rising 0.39 percent on Friday.
  • Myomo Inc (NYSE: MYO) shares fell 9.3 percent to $2.95 in pre-market trading after dropping 7.98 percent on Friday.
  • Sphere 3D Corp. (NASDAQ: ANY) fell 8.5 percent to $2.15 in pre-market trading after declining 0.84 percent on Friday.
  • Global Blood Therapeutics Inc (NASDAQ: GBT) shares fell 7.8 percent to $30.00 in pre-market trading after the company reported discontinuation of idiopathic pulmonary fibrosis program.
  • Westlake Chemical Corporation (NYSE: WLK) shares fell 5 percent to $79.68 in pre-market trading. Westlake Chemical is expected to release its Q3 earnings on Tuesday, November 7, 2017.
  • Mercadolibre Inc NASDAQ: MELI) fell 4.6 percent to $224.85 in pre-market trading. KeyBanc downgraded MercadoLibre from Overweight to Sector Weight.
  • IPG Photonics Corporation (NASDAQ: IPGP) shares fell 4.2 percent to $194.17 in pre-market trading after gaining 0.85 percent on Friday.
  • Viking Therapeutics Inc (NASDAQ: VKTX) shares fell 3.7 percent to $2.89 in pre-market trading. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo model of X-linked adrenoleukodystrophy.
  • Harsco Corporation (NYSE: HSC) fell 3.3 percent to $20.80 in the pre-market trading session. Harsco is projected to release Q3 results on November 8, 2017.
 

Related Articles (AGEN + ACRX)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com